Tips and Summary Fatigue in patients with chronic kidney disease (CKD) goes beyond mere tiredness, significantly lowering their quality of life. Causes such as anemia, uremic toxin buildup, electrolyte imbalances, and sleep disorders contribute to… Causes of Fatigue in Chronic Kidney Disease Patients and Coping Strategies
Maintain Serum Bicarbonate (HCO₃⁻) Levels of 22–26 mmol/LKeeping serum bicarbonate levels within 22–26 mmol/L may help slow CKD progression and support muscle preservation. Monitor Blood Pressure, Edema, and ElectrolytesIf you have hypertension, heart failure, or… Sodium Bicarbonate Supplementation for Chronic Kidney Disease: Can It Help Preserve Muscle?
1. What is the P2X7 Receptor? The Purinergic receptor P2X7 (P2X7) is an ionotropic purinergic receptor activated by adenosine triphosphate (ATP). It regulates the influx of calcium (Ca²⁺) and sodium (Na⁺) and the efflux of… A New Therapeutic Mechanism for Chronic Kidney Disease (CKD) Discovered: The Role of Purinergic Receptor P2X7
🔸 Summary of Key Goals Blood Sugar Control: HbA1c 6.5–7.0%, Fasting Blood Glucose 80–130 mg/dL Blood Pressure Control: Below 130/80 mmHg Proteinuria Reduction: UACR <30 mg/g, at least 50% reduction if present Dyslipidemia Management: LDL… Diabetes and Kidney Disease: Why Do They Occur Together and How to Manage Them Effectively?
Introduction: A Paradigm Shift in Chronic Kidney Disease Management Chronic Kidney Disease (CKD) is a progressive condition characterized by the gradual loss of kidney function due to various causes, including diabetes, hypertension, and glomerulonephritis. CKD… The Role of SGLT-2 Inhibitors in Chronic Kidney Disease: Clinical Applications, Precautions, and Future Directions
🚀 Checklist for Protecting Kidney Health✅ Maintain blood pressure below 130/80 mmHg (adjust based on kidney function)✅ Keep HbA1c below 7%✅ Follow a low-sodium, low-protein diet✅ Ensure proper hydration (avoid excessive fluid intake)✅ Avoid nephrotoxic… Checklist for Protecting Kidney Health | Summary of CKD Management
Introduction Sodium-glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as crucial pharmacological agents in managing type 2 diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD). These drug classes provide… Comprehensive Review of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Monotherapy vs. Combination Therapy in CKD and Cardiovascular Disease
1. Introduction: The Growing Burden of CKD in an Aging Society Chronic Kidney Disease eGFR interpretation in elderly patients, With the rapid aging of populations worldwide, the prevalence of chronic kidney disease (CKD) among elderly… Chronic Kidney Disease (CKD) Diagnosis in Elderly Patients: Understanding eGFR Interpretation and Age-Specific Cutoffs
1. Introduction Comparison of Acute Kidney Injury and Chronic Kidney Disease, Acute Kidney Injury (AKI) refers to the sudden deterioration of kidney function within hours or days. If detected early and managed properly, it is… Comparison of Acute Kidney Injury and Chronic Kidney Disease
Lupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus (SLE), affecting approximately 35–60% of patients. It can cause significant damage to kidney function, leading to chronic kidney disease (CKD) or… Lupus Nephritis: A New Approach to Treatment Goals – From Clinical to Immunologic Remission